Review
Copyright ©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 97458
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.97458
Figure 1
Figure 1 Common pathways and risk factors leading to endothelial dysfunction and major cardiovascular adverse events among post-kidney transplant recipients. AGEs: Advanced glycation end products; CKD: Chronic kidney disease; CVD: Cardiovascular diseases; FFA: Free fatty acids; FGF: Fibroblast growth factor; LVH: Left ventricular hypertrophy; NO: Nitric oxide; NODAT: New-onset diabetes after transplant; PTH: Parathyroid hormone; SES: Socioeconomic status.